Compare WAL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAL | LNTH |
|---|---|---|
| Founded | 1994 | 1956 |
| Country | United States | United States |
| Employees | 3524 | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 5.6B |
| IPO Year | N/A | 2014 |
| Metric | WAL | LNTH |
|---|---|---|
| Price | $76.55 | $93.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $91.69 | $87.00 |
| AVG Volume (30 Days) | ★ 1.0M | 833.3K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $20.49 | N/A |
| Revenue Next Year | $8.08 | $14.19 |
| P/E Ratio | ★ $10.88 | $52.26 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $65.82 | $47.27 |
| 52 Week High | $97.23 | $98.27 |
| Indicator | WAL | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 46.47 | 65.27 |
| Support Level | $74.13 | $72.35 |
| Resistance Level | $81.21 | N/A |
| Average True Range (ATR) | 2.43 | 3.24 |
| MACD | -0.80 | 0.47 |
| Stochastic Oscillator | 25.17 | 73.41 |
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.